O	O	0	6	Active	Active	B-NP	JJ	O	2	NMOD	O
O	O	7	18	suppression	suppression	I-NP	NN	O	14	SUB	O
O	O	19	21	of	of	B-PP	IN	O	2	NMOD	O
O	O	22	25	the	the	B-NP	DT	O	7	NMOD	O
T1	B-Protein	26	31	class	class	I-NP	NN	B-protein	7	NMOD	B-protein
T1	I-Protein	32	34	II	II	I-NP	CD	I-protein	7	NMOD	I-protein
T1	I-Protein	35	49	transactivator	transactivator	I-NP	NN	I-protein	3	PMOD	I-protein
T12	B-Entity	49	50	-	-	O	HYPH	O	2	P	O
T12	I-Entity	50	58	encoding	encode	B-VP	VBG	O	2	NMOD	O
T12	I-Entity	59	62	AIR	AIR	B-NP	NN	B-protein	13	NMOD	B-protein
T12	I-Entity	62	63	-	-	B-NP	HYPH	O	13	NMOD	O
T12	I-Entity	63	64	1	1	I-NP	CD	O	13	NMOD	O
T12	I-Entity	65	70	locus	locus	I-NP	NN	O	9	OBJ	O
O	O	71	73	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	74	85	responsible	responsible	B-ADJP	JJ	O	14	PRD	O
O	O	86	89	for	for	B-PP	IN	O	15	AMOD	O
O	O	90	93	the	the	B-NP	DT	O	18	NMOD	O
O	O	94	98	lack	lack	I-NP	NN	O	16	PMOD	O
O	O	99	101	of	of	B-PP	IN	O	18	NMOD	O
T13	B-Entity	102	107	major	major	B-NP	JJ	B-DNA	25	NMOD	B-DNA
T13	I-Entity	108	126	histocompatibility	histocompatibility	I-NP	NN	I-DNA	25	NMOD	I-DNA
T13	I-Entity	127	134	complex	complex	I-NP	NN	I-DNA	25	NMOD	I-DNA
T13	I-Entity	135	140	class	class	I-NP	NN	I-DNA	25	NMOD	I-DNA
T13	I-Entity	141	143	II	II	I-NP	CD	I-DNA	25	NMOD	I-DNA
T13	I-Entity	144	148	gene	gene	I-NP	NN	I-DNA	26	NMOD	I-DNA
O	O	149	159	expression	expression	I-NP	NN	O	19	PMOD	O
O	O	160	168	observed	observe	B-VP	VBN	O	26	NMOD	O
O	O	169	175	during	during	B-PP	IN	O	27	VMOD	O
O	O	176	191	differentiation	differentiation	B-NP	NN	O	28	PMOD	O
O	O	192	196	from	from	B-PP	IN	O	29	NMOD	O
O	O	197	198	B	B	B-NP	NN	B-cell_type	32	NMOD	B-cell_type
O	O	199	204	cells	cell	I-NP	NNS	I-cell_type	30	PMOD	I-cell_type
O	O	205	207	to	to	B-PP	TO	O	29	NMOD	O
O	O	208	214	plasma	plasma	B-NP	NN	B-cell_type	35	NMOD	B-cell_type
O	O	215	220	cells	cell	I-NP	NNS	I-cell_type	33	PMOD	I-cell_type
O	O	220	221	.	.	O	.	O	14	P	O

O	O	223	225	In	In	B-PP	IN	O	27	VMOD	O
O	O	226	230	this	this	B-NP	DT	O	3	NMOD	O
O	O	231	236	study	study	I-NP	NN	O	1	PMOD	O
O	O	237	240	the	the	B-NP	DT	O	6	NMOD	O
O	O	241	248	genetic	genetic	I-NP	JJ	O	6	NMOD	O
O	O	249	256	control	control	I-NP	NN	O	27	SUB	O
O	O	257	259	of	of	B-PP	IN	O	6	NMOD	O
T14	B-Entity	260	265	major	major	B-NP	JJ	B-DNA	17	NMOD	B-DNA
T14	I-Entity	266	284	histocompatibility	histocompatibility	I-NP	NN	I-DNA	17	NMOD	I-DNA
T14	I-Entity	285	292	complex	complex	I-NP	NN	I-DNA	17	NMOD	I-DNA
T14	I-Entity	293	294	(	(	O	(	I-DNA	17	NMOD	I-DNA
T14	I-Entity	294	297	MHC	MHC	B-NP	NN	I-DNA	17	NMOD	I-DNA
T14	I-Entity	297	298	)	)	O	)	I-DNA	17	NMOD	I-DNA
T14	I-Entity	299	304	class	class	B-NP	NN	I-DNA	17	NMOD	I-DNA
T14	I-Entity	305	307	II	II	I-NP	CD	I-DNA	17	NMOD	I-DNA
T14	I-Entity	308	312	gene	gene	I-NP	NN	I-DNA	17	NMOD	I-DNA
O	O	313	323	expression	expression	I-NP	NN	O	7	PMOD	O
O	O	324	330	during	during	B-PP	IN	O	6	NMOD	O
O	O	331	334	the	the	B-NP	DT	O	20	NMOD	O
O	O	335	345	transition	transition	I-NP	NN	O	18	PMOD	O
O	O	346	350	from	from	B-PP	IN	O	20	NMOD	O
O	O	351	352	B	B	B-NP	NN	B-cell_type	23	NMOD	B-cell_type
O	O	353	357	cell	cell	I-NP	NN	I-cell_type	21	PMOD	I-cell_type
O	O	358	360	to	to	B-PP	TO	O	20	NMOD	O
O	O	361	367	plasma	plasma	B-NP	NN	B-cell_type	26	NMOD	B-cell_type
O	O	368	372	cell	cell	I-NP	NN	I-cell_type	24	PMOD	I-cell_type
O	O	373	376	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	377	381	been	be	I-VP	VBN	O	27	VC	O
O	O	382	390	analyzed	analyze	I-VP	VBN	O	28	VC	O
O	O	390	391	.	.	O	.	O	27	P	O

O	O	392	397	Class	Class	B-NP	NN	B-protein	3	NMOD	B-protein
O	O	398	400	II	II	B-NP	CD	I-protein	3	NMOD	I-protein
O	O	401	410	molecules	molecule	I-NP	NNS	I-protein	4	SUB	I-protein
O	O	411	414	are	be	B-VP	VBP	O	0	ROOT	O
O	O	415	418	not	not	I-VP	RB	O	4	VMOD	O
O	O	419	428	expressed	express	I-VP	VBN	O	4	VC	O
O	O	429	431	in	in	B-PP	IN	O	6	VMOD	O
O	O	432	438	plasma	plasma	B-NP	NN	B-cell_type	9	NMOD	B-cell_type
O	O	439	444	cells	cell	I-NP	NNS	I-cell_type	7	PMOD	I-cell_type
O	O	445	452	because	because	B-PP	IN	O	6	VMOD	O
O	O	453	455	of	of	I-PP	IN	O	10	PMOD	O
O	O	456	458	an	an	B-NP	DT	O	14	NMOD	O
O	O	459	465	active	active	I-NP	JJ	O	14	NMOD	O
O	O	466	477	suppression	suppression	I-NP	NN	O	10	PMOD	O
O	O	478	487	resulting	result	B-VP	VBG	O	14	NMOD	O
O	O	488	490	in	in	B-PP	IN	O	15	VMOD	O
O	O	491	494	the	the	B-NP	DT	O	18	NMOD	O
O	O	495	505	abrogation	abrogation	I-NP	NN	O	16	PMOD	O
O	O	506	508	of	of	B-PP	IN	O	18	NMOD	O
T15	B-Entity	509	514	class	class	B-NP	NN	B-DNA	23	NMOD	B-DNA
T15	I-Entity	515	517	II	II	I-NP	CD	I-DNA	23	NMOD	I-DNA
T15	I-Entity	518	522	gene	gene	I-NP	NN	I-DNA	23	NMOD	I-DNA
O	O	523	536	transcription	transcription	I-NP	NN	O	19	PMOD	O
O	O	536	537	.	.	O	.	O	4	P	O

O	O	538	540	We	We	B-NP	PRP	O	2	SUB	O
O	O	541	545	show	show	B-VP	VBP	O	0	ROOT	O
O	O	546	550	here	here	B-ADVP	RB	O	2	VMOD	O
O	O	551	555	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	556	559	the	the	B-NP	DT	O	7	NMOD	O
O	O	560	566	plasma	plasma	I-NP	NN	B-cell_type	7	NMOD	B-cell_type
O	O	567	571	cell	cell	I-NP	NN	I-cell_type	11	NMOD	I-cell_type
O	O	571	572	-	-	B-NP	HYPH	O	11	NMOD	O
O	O	572	580	specific	specific	I-NP	JJ	O	11	NMOD	O
O	O	581	590	repressor	repressor	I-NP	NN	O	11	NMOD	O
O	O	591	599	function	function	I-NP	NN	O	23	SUB	O
O	O	599	600	,	,	O	,	O	11	P	O
O	O	601	611	designated	designate	B-VP	VBN	O	11	NMOD	O
T16	B-Entity	612	615	SIR	SIR	B-NP	NN	B-DNA	13	VMOD	B-DNA
O	O	616	617	(	(	O	(	O	21	DEP	O
T17	B-Entity	617	627	suppressor	suppressor	B-NP	NN	O	21	DEP	O
T17	I-Entity	628	630	of	of	B-PP	IN	O	16	NMOD	O
T17	I-Entity	631	637	immune	immune	B-NP	JJ	B-DNA	20	NMOD	B-DNA
T17	I-Entity	638	646	response	response	I-NP	NN	I-DNA	20	NMOD	I-DNA
T17	I-Entity	647	652	genes	gene	I-NP	NNS	I-DNA	17	PMOD	I-DNA
O	O	652	653	)	)	O	)	O	14	NMOD	O
O	O	653	654	,	,	O	,	O	11	P	O
O	O	655	659	does	do	B-VP	VBZ	O	4	SBAR	O
O	O	660	663	not	not	I-VP	RB	O	23	VMOD	O
O	O	664	667	act	act	I-VP	VB	O	23	VC	O
O	O	668	676	directly	directly	B-ADVP	RB	O	25	VMOD	O
O	O	677	679	on	on	B-PP	IN	O	25	VMOD	O
O	O	680	683	the	the	B-NP	DT	O	29	NMOD	O
O	O	684	697	transcription	transcription	I-NP	NN	O	27	PMOD	O
O	O	698	700	of	of	B-PP	IN	O	29	NMOD	O
T18	B-Entity	701	706	class	class	B-NP	NN	B-DNA	33	NMOD	B-DNA
T18	I-Entity	707	709	II	II	I-NP	CD	I-DNA	33	NMOD	I-DNA
T18	I-Entity	710	715	genes	gene	I-NP	NNS	I-DNA	30	PMOD	I-DNA
O	O	715	716	,	,	O	,	O	23	P	O
O	O	717	720	but	but	O	CC	O	23	VMOD	O
O	O	721	728	instead	instead	B-ADVP	RB	O	23	VMOD	O
O	O	729	731	on	on	B-PP	IN	O	36	AMOD	O
O	O	732	735	the	the	B-NP	DT	O	39	NMOD	O
O	O	736	749	transcription	transcription	I-NP	NN	O	37	PMOD	O
O	O	750	752	of	of	B-PP	IN	O	39	NMOD	O
O	O	753	756	the	the	B-NP	DT	O	45	NMOD	O
T19	B-Entity	757	760	AIR	AIR	I-NP	NN	B-DNA	45	NMOD	B-DNA
T19	I-Entity	760	761	-	-	B-NP	HYPH	I-DNA	45	NMOD	I-DNA
T19	I-Entity	761	762	1	1	I-NP	CD	I-DNA	45	NMOD	I-DNA
T19	I-Entity	763	767	gene	gene	I-NP	NN	I-DNA	48	NMOD	I-DNA
O	O	767	768	,	,	O	,	O	45	P	O
O	O	769	774	whose	whose	B-NP	WP$	O	48	NMOD	O
O	O	775	782	product	product	I-NP	NN	O	53	NMOD	O
O	O	782	783	,	,	O	,	O	53	P	O
O	O	784	787	the	the	B-NP	DT	O	53	NMOD	O
T2	B-Protein	788	793	class	class	I-NP	NN	B-protein	53	NMOD	B-protein
T2	I-Protein	794	796	II	II	I-NP	CD	I-protein	53	NMOD	I-protein
T2	I-Protein	797	811	transactivator	transactivator	I-NP	NN	I-protein	40	PMOD	I-protein
O	O	812	813	(	(	O	(	O	56	DEP	O
T3	B-Protein	813	818	CIITA	CIITA	B-NP	NN	B-protein	56	DEP	B-protein
O	O	818	819	)	)	O	)	O	53	NMOD	O
O	O	819	820	,	,	O	,	O	23	P	O
O	O	821	823	is	be	B-VP	VBZ	O	23	VMOD	O
O	O	824	835	fundamental	fundamental	B-ADJP	JJ	O	58	PRD	O
O	O	836	839	for	for	B-PP	IN	O	59	AMOD	O
O	O	840	843	the	the	B-NP	DT	O	62	NMOD	O
O	O	844	854	regulation	regulation	I-NP	NN	O	60	PMOD	O
O	O	855	857	of	of	B-PP	IN	O	62	NMOD	O
O	O	858	861	the	the	B-NP	DT	O	68	NMOD	O
O	O	862	874	constitutive	constitutive	I-NP	JJ	O	67	AMOD	O
O	O	875	878	and	and	I-NP	CC	O	67	AMOD	O
O	O	879	888	inducible	inducible	I-NP	JJ	O	68	NMOD	O
O	O	889	899	expression	expression	I-NP	NN	O	63	PMOD	O
O	O	900	902	of	of	B-PP	IN	O	68	NMOD	O
T20	B-Entity	903	906	MHC	MHC	B-NP	NN	B-DNA	73	NMOD	B-DNA
T20	I-Entity	907	912	class	class	I-NP	NN	I-DNA	73	NMOD	I-DNA
T20	I-Entity	913	915	II	II	B-NP	CD	I-DNA	73	NMOD	I-DNA
T20	I-Entity	916	921	genes	gene	I-NP	NNS	I-DNA	69	PMOD	I-DNA
O	O	921	922	.	.	O	.	O	2	P	O

O	O	923	927	This	This	B-NP	DT	O	2	SUB	O
O	O	928	931	was	be	B-VP	VBD	O	0	ROOT	O
O	O	932	945	unambiguously	unambiguously	I-VP	RB	O	2	VMOD	O
O	O	946	958	demonstrated	demonstrate	I-VP	VBN	O	2	VC	O
O	O	959	961	by	by	B-PP	IN	O	4	VMOD	O
O	O	962	965	the	the	B-NP	DT	O	7	NMOD	O
O	O	966	970	fact	fact	I-NP	NN	O	5	PMOD	O
O	O	971	975	that	that	B-SBAR	IN	O	7	NMOD	O
O	O	976	988	plasmacytoma	plasmacytoma	B-NP	NN	B-cell_line	13	NMOD	B-cell_line
O	O	989	990	x	x	I-NP	NN	I-cell_line	13	NMOD	I-cell_line
O	O	991	992	B	B	I-NP	NN	I-cell_line	13	NMOD	I-cell_line
O	O	993	997	cell	cell	I-NP	NN	I-cell_line	13	NMOD	I-cell_line
O	O	998	1005	hybrids	hybrid	I-NP	NNS	I-cell_line	26	SUB	I-cell_line
O	O	1006	1014	carrying	carry	B-VP	VBG	O	13	NMOD	O
O	O	1015	1017	an	an	B-NP	DT	O	19	NMOD	O
T21	B-Entity	1018	1021	AIR	AIR	I-NP	NN	B-DNA	19	NMOD	B-DNA
T21	I-Entity	1021	1022	-	-	B-NP	HYPH	I-DNA	19	NMOD	I-DNA
T21	I-Entity	1022	1023	1	1	I-NP	CD	I-DNA	19	NMOD	I-DNA
T21	I-Entity	1024	1029	locus	locus	I-NP	NN	I-DNA	14	OBJ	I-DNA
O	O	1030	1037	derived	derive	B-VP	VBN	O	19	NMOD	O
O	O	1038	1042	from	from	B-PP	IN	O	20	VMOD	O
T4	B-Protein	1043	1048	CIITA	CIITA	B-NP	NN	B-protein	25	NMOD	B-protein
O	O	1048	1049	-	-	B-PP	HYPH	O	25	NMOD	O
O	O	1049	1059	expressing	express	B-NP	VBG	B-cell_type	25	NMOD	B-cell_type
O	O	1060	1065	cells	cell	I-NP	NNS	I-cell_type	21	PMOD	I-cell_type
O	O	1066	1068	do	do	B-VP	VBP	O	8	SBAR	O
O	O	1069	1072	not	not	I-VP	RB	O	26	VMOD	O
O	O	1073	1080	express	express	I-VP	VB	O	26	VC	O
T5	B-Protein	1081	1086	CIITA	CIITA	B-NP	NN	B-protein	32	NMOD	B-protein
O	O	1086	1087	-	-	B-NP	HYPH	O	32	P	O
O	O	1087	1095	specific	specific	I-NP	JJ	O	32	NMOD	O
O	O	1096	1107	transcripts	transcript	I-NP	NNS	O	28	OBJ	O
O	O	1107	1108	.	.	O	.	O	2	P	O

O	O	1109	1121	Transfection	Transfection	B-NP	NN	O	18	SUB	O
O	O	1122	1124	of	of	B-PP	IN	O	1	NMOD	O
O	O	1125	1126	a	a	B-NP	DT	O	4	NMOD	O
O	O	1127	1131	cDNA	cDNA	I-NP	NN	B-DNA	2	PMOD	B-DNA
O	O	1132	1142	containing	contain	B-VP	VBG	O	4	NMOD	O
O	O	1143	1146	the	the	B-NP	DT	O	10	NMOD	O
O	O	1147	1152	human	human	I-NP	JJ	B-DNA	10	NMOD	B-DNA
T6	B-Protein	1153	1158	CIITA	CIITA	I-NP	NN	I-DNA	10	NMOD	I-DNA
T22	B-Entity	1159	1165	coding	coding	I-NP	NN	I-DNA	10	NMOD	I-DNA
T22	I-Entity	1166	1174	sequence	sequence	I-NP	NN	I-DNA	5	OBJ	I-DNA
O	O	1175	1180	under	under	B-PP	IN	O	1	NMOD	O
O	O	1181	1184	the	the	B-NP	DT	O	13	NMOD	O
O	O	1185	1192	control	control	I-NP	NN	O	11	PMOD	O
O	O	1193	1195	of	of	B-PP	IN	O	13	NMOD	O
O	O	1196	1198	an	an	B-NP	DT	O	17	NMOD	O
T23	B-Entity	1199	1211	heterologous	heterologous	I-NP	JJ	B-DNA	17	NMOD	B-DNA
T23	I-Entity	1212	1220	promoter	promoter	I-NP	NN	I-DNA	14	PMOD	I-DNA
O	O	1221	1229	restores	restore	B-VP	VBZ	O	0	ROOT	O
O	O	1230	1240	expression	expression	B-NP	NN	O	18	OBJ	O
O	O	1241	1243	of	of	B-PP	IN	O	19	NMOD	O
T24	B-Entity	1244	1249	human	human	B-NP	JJ	B-DNA	25	NMOD	B-DNA
T24	I-Entity	1250	1253	MHC	MHC	I-NP	NN	I-DNA	25	NMOD	I-DNA
T24	I-Entity	1254	1259	class	class	I-NP	NN	I-DNA	25	NMOD	I-DNA
T24	I-Entity	1260	1262	II	II	B-NP	CD	I-DNA	25	NMOD	I-DNA
T24	I-Entity	1263	1268	genes	gene	I-NP	NNS	I-DNA	20	PMOD	I-DNA
O	O	1269	1271	in	in	B-PP	IN	O	19	NMOD	O
O	O	1272	1275	the	the	B-NP	DT	O	28	NMOD	O
O	O	1276	1283	hybrids	hybrid	I-NP	NNS	O	26	PMOD	O
O	O	1284	1287	and	and	O	CC	O	18	VMOD	O
O	O	1288	1290	is	be	B-VP	VBZ	O	18	VMOD	O
O	O	1291	1302	responsible	responsible	B-ADJP	JJ	O	30	PRD	O
O	O	1303	1306	for	for	B-PP	IN	O	31	AMOD	O
O	O	1307	1309	de	de	B-NP	FW	O	34	AMOD	O
O	O	1310	1314	novo	novo	I-NP	FW	O	35	NMOD	O
O	O	1315	1325	expression	expression	I-NP	NN	O	32	PMOD	O
O	O	1326	1328	of	of	B-PP	IN	O	35	NMOD	O
T25	B-Entity	1329	1334	mouse	mouse	B-NP	NN	B-DNA	41	NMOD	B-DNA
T25	I-Entity	1335	1338	MHC	MHC	I-NP	NN	I-DNA	41	NMOD	I-DNA
T25	I-Entity	1339	1344	class	class	I-NP	NN	I-DNA	41	NMOD	I-DNA
T25	I-Entity	1345	1347	II	II	B-NP	CD	I-DNA	41	NMOD	I-DNA
T25	I-Entity	1348	1353	genes	gene	I-NP	NNS	I-DNA	36	PMOD	I-DNA
O	O	1354	1356	in	in	B-PP	IN	O	35	NMOD	O
O	O	1357	1361	both	both	O	CC	O	51	NMOD	O
O	O	1362	1365	the	the	B-NP	DT	O	48	NMOD	O
O	O	1366	1371	mouse	mouse	I-NP	NN	B-cell_line	48	NMOD	B-cell_line
O	O	1372	1384	plasmacytoma	plasmacytoma	I-NP	NN	I-cell_line	48	NMOD	I-cell_line
O	O	1385	1389	cell	cell	I-NP	NN	I-cell_line	48	NMOD	I-cell_line
O	O	1390	1394	line	line	I-NP	NN	I-cell_line	51	NMOD	I-cell_line
O	O	1395	1398	and	and	O	CC	O	51	NMOD	O
O	O	1399	1402	the	the	B-NP	DT	O	51	NMOD	O
O	O	1403	1410	hybrids	hybrid	I-NP	NNS	B-cell_line	42	PMOD	B-cell_line
O	O	1410	1411	.	.	O	.	O	18	P	O

O	O	1412	1417	These	These	B-NP	DT	O	2	NMOD	O
O	O	1418	1425	results	result	I-NP	NNS	O	3	SUB	O
O	O	1426	1433	confirm	confirm	B-VP	VBP	O	0	ROOT	O
O	O	1434	1437	and	and	I-VP	CC	O	3	VMOD	O
O	O	1438	1444	extend	extend	I-VP	VBP	O	3	VMOD	O
O	O	1445	1448	the	the	B-NP	DT	O	7	NMOD	O
O	O	1449	1455	notion	notion	I-NP	NN	O	3	VMOD	O
O	O	1456	1458	of	of	B-PP	IN	O	7	NMOD	O
O	O	1459	1462	the	the	B-NP	DT	O	11	NMOD	O
O	O	1463	1473	functional	functional	I-NP	JJ	O	11	NMOD	O
O	O	1474	1486	conservation	conservation	I-NP	NN	O	8	PMOD	O
O	O	1487	1489	of	of	B-PP	IN	O	11	NMOD	O
O	O	1490	1493	the	the	B-NP	DT	O	18	NMOD	O
O	O	1494	1497	AIR	AIR	I-NP	NN	B-protein	18	NMOD	B-protein
O	O	1497	1498	-	-	B-NP	HYPH	I-protein	18	NMOD	I-protein
O	O	1498	1499	1	1	I-NP	CD	I-protein	18	NMOD	I-protein
O	O	1500	1504	gene	gene	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	1505	1512	product	product	I-NP	NN	I-protein	12	PMOD	I-protein
O	O	1513	1519	across	across	B-PP	IN	O	11	NMOD	O
O	O	1520	1527	species	specie	B-NP	NNS	O	21	NMOD	O
O	O	1528	1536	barriers	barrier	I-NP	NNS	O	19	PMOD	O
O	O	1536	1537	.	.	O	.	O	3	P	O

O	O	1538	1551	Interestingly	Interestingly	B-ADVP	RB	O	20	VMOD	O
O	O	1551	1552	,	,	O	,	O	20	P	O
O	O	1553	1555	in	in	B-PP	IN	O	20	VMOD	O
T7	B-Protein	1556	1561	CIITA	CIITA	B-NP	NN	B-cell_line	8	NMOD	B-cell_line
O	O	1561	1562	-	-	O	HYPH	I-cell_line	8	NMOD	I-cell_line
O	O	1562	1573	transfected	transfecte	B-NP	VBN	I-cell_line	8	NMOD	I-cell_line
O	O	1574	1578	cell	cell	I-NP	NN	I-cell_line	8	NMOD	I-cell_line
O	O	1579	1586	hybrids	hybrid	I-NP	NNS	I-cell_line	3	PMOD	I-cell_line
O	O	1586	1587	,	,	O	,	O	20	P	O
O	O	1588	1592	cell	cell	B-NP	NN	O	12	NMOD	O
O	O	1593	1600	surface	surface	I-NP	NN	O	12	NMOD	O
O	O	1601	1611	expression	expression	I-NP	NN	O	20	SUB	O
O	O	1612	1614	of	of	B-PP	IN	O	12	NMOD	O
O	O	1615	1618	the	the	B-NP	DT	O	19	NMOD	O
T26	B-Entity	1619	1624	human	human	I-NP	JJ	B-protein	19	NMOD	B-protein
T26	I-Entity	1625	1628	HLA	HLA	I-NP	NN	I-protein	19	NMOD	I-protein
T26	I-Entity	1628	1629	-	-	I-NP	HYPH	I-protein	19	NMOD	I-protein
T26	I-Entity	1629	1631	DQ	DQ	I-NP	NN	I-protein	19	NMOD	I-protein
T26	I-Entity	1632	1643	heterodimer	heterodimer	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	1644	1647	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1648	1651	not	not	I-VP	RB	O	20	VMOD	O
O	O	1652	1660	observed	observe	I-VP	VBN	O	20	VC	O
O	O	1660	1661	.	.	O	.	O	20	P	O

O	O	1662	1666	This	This	B-NP	DT	O	2	NMOD	O
O	O	1667	1673	result	result	I-NP	NN	O	3	SUB	O
O	O	1674	1677	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1678	1681	not	not	O	RB	O	3	VMOD	O
O	O	1682	1694	attributable	attributable	B-ADJP	JJ	O	3	PRD	O
O	O	1695	1697	to	to	B-PP	TO	O	5	AMOD	O
O	O	1698	1702	lack	lack	B-NP	NN	O	6	PMOD	O
O	O	1703	1705	of	of	B-PP	IN	O	7	NMOD	O
T8	B-Protein	1706	1709	HLA	HLA	B-NP	NN	B-protein	17	NMOD	B-protein
T8	I-Protein	1709	1710	-	-	B-NP	HYPH	O	17	NMOD	O
T8	I-Protein	1710	1712	DQ	DQ	I-NP	NN	O	17	NMOD	O
T8	I-Protein	1713	1718	alpha	alpha	B-VP	SYM	O	17	NMOD	O
O	O	1719	1721	or	or	O	CC	O	17	NMOD	O
T9	B-Protein	1722	1723	-	-	O	HYPH	O	17	NMOD	O
T9	I-Protein	1723	1725	DQ	DQ	B-NP	NN	O	17	NMOD	O
T9	I-Protein	1726	1730	beta	beta	I-NP	NN	O	17	NMOD	O
O	O	1731	1744	transcription	transcription	I-NP	NN	O	8	PMOD	O
O	O	1744	1745	,	,	O	,	O	3	P	O
O	O	1746	1753	because	because	B-SBAR	IN	O	3	VMOD	O
O	O	1754	1758	both	both	B-NP	DT	O	21	NMOD	O
O	O	1759	1770	transcripts	transcript	I-NP	NNS	O	22	SUB	O
O	O	1771	1775	were	be	B-VP	VBD	O	19	SBAR	O
O	O	1776	1783	present	present	B-ADJP	JJ	O	22	PRD	O
O	O	1784	1786	in	in	B-PP	IN	O	23	AMOD	O
O	O	1787	1790	the	the	B-NP	DT	O	29	NMOD	O
T10	B-Protein	1791	1796	CIITA	CIITA	I-NP	NN	B-cell_line	29	NMOD	B-cell_line
O	O	1796	1797	-	-	B-NP	HYPH	I-cell_line	29	NMOD	I-cell_line
O	O	1797	1808	transfected	transfecte	I-NP	VBN	I-cell_line	29	NMOD	I-cell_line
O	O	1809	1816	hybrids	hybrid	I-NP	NNS	I-cell_line	24	PMOD	I-cell_line
O	O	1816	1817	,	,	O	,	O	22	P	O
O	O	1818	1826	although	although	B-SBAR	IN	O	22	VMOD	O
O	O	1827	1829	at	at	B-PP	IN	O	31	DEP	O
O	O	1830	1837	reduced	reduce	B-NP	VBN	O	34	NMOD	O
O	O	1838	1844	levels	level	I-NP	NNS	O	32	PMOD	O
O	O	1844	1845	.	.	O	.	O	3	P	O

O	O	1846	1851	These	These	B-NP	DT	O	2	NMOD	O
O	O	1852	1860	findings	finding	I-NP	NNS	O	4	SUB	O
O	O	1861	1868	further	further	B-ADVP	RB	O	4	VMOD	O
O	O	1869	1876	support	support	B-VP	VBP	O	0	ROOT	O
O	O	1877	1880	our	our	B-NP	PRP$	O	7	NMOD	O
O	O	1881	1889	previous	previous	I-NP	JJ	O	7	NMOD	O
O	O	1890	1902	observations	observation	I-NP	NNS	O	4	OBJ	O
O	O	1903	1905	on	on	B-PP	IN	O	7	NMOD	O
O	O	1906	1909	the	the	B-NP	DT	O	11	NMOD	O
O	O	1910	1918	distinct	distinct	I-NP	JJ	O	11	NMOD	O
O	O	1919	1929	regulation	regulation	I-NP	NN	O	8	PMOD	O
O	O	1930	1932	of	of	B-PP	IN	O	11	NMOD	O
O	O	1933	1943	expression	expression	B-NP	NN	O	12	PMOD	O
O	O	1944	1946	of	of	B-PP	IN	O	13	NMOD	O
O	O	1947	1950	the	the	B-NP	DT	O	22	NMOD	O
T27	B-Entity	1951	1956	human	human	I-NP	JJ	B-DNA	22	NMOD	B-DNA
T27	I-Entity	1957	1960	HLA	HLA	I-NP	NN	I-DNA	22	NMOD	I-DNA
T27	I-Entity	1960	1961	-	-	O	HYPH	I-DNA	22	NMOD	I-DNA
T27	I-Entity	1961	1963	DQ	DQ	B-NP	NN	I-DNA	22	NMOD	I-DNA
T27	I-Entity	1964	1969	class	class	I-NP	NN	I-DNA	22	NMOD	I-DNA
T27	I-Entity	1970	1972	II	II	I-NP	CD	I-DNA	22	NMOD	I-DNA
T27	I-Entity	1973	1979	subset	subset	I-NP	NN	I-DNA	14	PMOD	I-DNA
O	O	1979	1980	,	,	O	,	O	22	P	O
O	O	1981	1986	which	which	B-NP	WDT	O	22	NMOD	O
O	O	1987	1990	may	may	B-VP	MD	O	24	SBAR	O
O	O	1991	1993	be	be	I-VP	VB	O	25	VC	O
O	O	1994	1998	thus	thus	I-VP	RB	O	26	VMOD	O
O	O	1999	2009	controlled	control	I-VP	VBN	O	26	VC	O
O	O	2010	2012	at	at	B-PP	IN	O	28	VMOD	O
O	O	2013	2016	the	the	B-NP	DT	O	32	NMOD	O
O	O	2017	2036	posttranscriptional	posttranscriptional	I-NP	JJ	O	32	NMOD	O
O	O	2037	2042	level	level	I-NP	NN	O	29	PMOD	O
O	O	2043	2045	by	by	B-PP	IN	O	28	VMOD	O
O	O	2046	2047	a	a	B-NP	DT	O	38	NMOD	O
T11	B-Protein	2048	2053	CIITA	CIITA	I-NP	NN	B-protein	38	NMOD	B-protein
O	O	2053	2054	-	-	B-NP	HYPH	O	38	NMOD	O
O	O	2054	2065	independent	independent	I-NP	JJ	O	38	NMOD	O
O	O	2066	2075	mechanism	mechanism	I-NP	NN	O	33	PMOD	O
O	O	2075	2076	.	.	O	.	O	4	P	O
